Go back to News
NEWS
GA_P advises Making Science on the repurchase of bonds listed in MARF and the subscription of a syndicated loan
Gómez-Acebo & Pombo advised Making Science, a Spanish digital acceleration multinational listed on BME Growth, on the repurchase and redemption of corporate bonds traded on the Alternative Fixed Income Market (“MARF”) and on the launch and syndication of a corporate bond, which will be composed of several tranches.
Both operations are part of Making Science’s international expansion process, highlighting its latest acquisitions in Georgia, Sweden, Denmark and the landing and now organic growth in the US market. Through this operation, the company adapts its financial structure to its current financing needs and to its national and international development plans for the coming years.
The GA_P team was led by Guillermo Guerra, partner of the Corporate Department and supported by José Francisco Canalejas and Irene Medina, associates of the Banking and Finance Department.
Read full article
Both operations are part of Making Science’s international expansion process, highlighting its latest acquisitions in Georgia, Sweden, Denmark and the landing and now organic growth in the US market. Through this operation, the company adapts its financial structure to its current financing needs and to its national and international development plans for the coming years.
The GA_P team was led by Guillermo Guerra, partner of the Corporate Department and supported by José Francisco Canalejas and Irene Medina, associates of the Banking and Finance Department.
Read full article
Press contact

Sandra Cuesta
Director of Business Development, Marketing and Communications

Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
2 days ago
Treatment within insolvency proceedings of claims arising from post-composition clawbacks
In Judgment no. 519/2025 of 1 April, the Supreme Court tackles the treatment to be given within insolvency proceedings to a claim acknowledged by way of court-ordered clawback (avoidance) prior to court approval of a composition.
PUBLICATION
One week ago
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
30 Jun, 2025
Main changes introduced by RDL 7/2025 to the milestone system applied in the processing of renewable energy generation projects
Royal Decree-law 7/2025 introduces new regulations which modify and extend the milestone system applied in the processing of renewable energy generation projects
PUBLICATION
30 Jun, 2025
Main changes introduced by RDL 7/2025 regarding electricity storage projects
Royal Decree-law 7/2025 introduces regulatory changes to the processing and deployment of electricity storage projects
PUBLICATION
19 Jun, 2025
Company resolutions reached with invalid votes
Although Article 204(3)(d) places them on the same level, the erroneous counting of votes and the counting of invalid votes are very different, given that the latter requires judicial balancing.
PUBLICATION
13 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (IV): the recognition and enforcement of court decisions
The Unified Patent Court has jurisdiction, in certain cases and within the limits set by the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not party to the Agreement on a Unified Patent Court. Such decisions may be recognised and enforced in those other countries, but there are cases in which such recognition and enforcement will not be appropriate.
PUBLICATION
12 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (III): applicable law
The Unified Patent Court has jurisdiction, in certain cases and within the limits laid down in the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not contracting parties to the Agreement on a Unified Patent Court. However, this does not mean that, when hearing such actions, the Court may apply the same rules as if the actions related to a unitary patent.
PUBLICATION
11 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (II): the controversial judgment of the Court of Justice in the BSH/Electrolux case
This document sets out and criticises the doctrine established by the CJEU in its Judgment of 25 February 2025, C-339/22, BSH/Electrolux, ECLI:EU:C:2025:108. Although the dispute underlying the judgment was not brought before the UPC, the interpretation of the CJEU in the BSH/Electrolux judgment is equally applicable, since said court is equivalent to the national courts of the contracting states party to the UPC Agreement.
PUBLICATION
10 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (I): international jurisdiction
Ever since coming into operation, there has been a tendency on the part of the Unified Patent Court to extend its jurisdiction to include patents that produce effects in States that are not party to the Agreement on a Unified Patent Court (the ‘UPC Agreement’ or ‘Agreement’), as is the case of the Kingdom of Spain. This phenomenon is known in specialised circles as the court's ‘long arm’. However, although in certain cases the Unified Patent Court (the ‘UPC’ or ‘Court’) does indeed have such jurisdiction, this is only possible within strict limits, limits that do not seem to be taken into consideration in a consistent manner.